BIOL Biolase
- 0.1500
- +0.0020+1.35%
Biolase News
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
Biolase Is Maintained at Buy by Ascendiant Capital
Biolase Is Maintained at Buy by Ascendiant Capital
Ascendiant Capital Maintains Buy on Biolase, Lowers Price Target to $4
Ascendiant Capital analyst Edward Woo maintains Biolase (NASDAQ:BIOL) with a Buy and lowers the price target from $15 to $4.
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
Biolase's Strong Q4 Performance and Positive 2024 Outlook Affirm Buy Rating
Biolase Is Maintained at Speculative Buy by Benchmark
Biolase Is Maintained at Speculative Buy by Benchmark
Biolase Price Target Cut to $0.40/Share From $2.50 by Benchmark
Biolase Price Target Cut to $0.40/Share From $2.50 by Benchmark
Benchmark Maintains Speculative Buy on Biolase, Lowers Price Target to $0.4
Benchmark analyst Bruce Jackson maintains Biolase with a Speculative Buy and lowers the price target from $2.5 to $0.4.
Biolase Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/22/2024 112.77% Benchmark $2.5 → $0.4 Maintains Speculative Buy 05/31/2023 112.77% Lake Street $1.5 → $
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 als
Biolase Shares Jump 27% After Upbeat 2024 Revenue Guidance
By Zaeem Shoaib Shares of Biolase were higher Friday after the company provided guidance for an increase in revenue in 2024. Biolase's shares were up 27% to 19.1 cents in recent trading. The stock h
Why BIOLASE Shares Are Surging Friday
BIOLASE, Inc. (NASDAQ:BIOL) shares are surging after the company reported better-than-expected fourth-quarter FY23 EPS results.Revenue of $13.49 million missed the consensus of $13.55 million. Gross p
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the NASDAQ fell 0.10% to 16,385.60. The S&P 500 also fell, dropping, 0
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersBiolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. The market value of their outstanding shares is at $4.6 million. The company's, Q4 earnings came
US Stock Futures Flat Ahead of Powell Speech After Reaching Record Highs on Thursday
US stock futures were flat in Friday's premarket session after equity indexes closed at record highs on Thursday, as investors awaited Federal Reserve Chairman Jerome Powell's speech, scheduled for 9:
Outlook OTLK Positive CHMP Opinion; BIOLASE BIOL Earnings
Top Premarket Gainers
Biolase (BIOL) shares surged nearly 72% in recent Friday premarket activity, a day after it reported a narrower Q4 net loss per share from a year earlier. Nova LifeStyle (NVFY) shares jumped 76%, addi
Q4 2023 BIOLASE Inc Earnings Call
BIOLASE, Inc. (BIOL) Witnesses Remarkable Surge With Earnings Beat
BIOLASE, Inc. (NASDAQ: BIOL) saw a relatively subdued trading day on Thursday, with its shares ticking up by a marginal 0.60% from $0.1491 to $0.1500. However, the after-market scenario presented a starkly different narrative. Following the unveiling of its earnings report, BIOLASE experienced an astounding surge of 47%, propelling its stock price north of the ...
Analysis
Price Target
No Data
